116 related articles for article (PubMed ID: 23580638)
1. The impact of abn(17p) and monosomy -5/del(5q) on the prognostic value of the monosomal karyotype in acute myeloid leukemia.
Breems DA; Van Putten WL; Löwenberg B
Blood; 2013 Apr; 121(15):3056-7. PubMed ID: 23580638
[No Abstract] [Full Text] [Related]
2. Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
Poiré X; Labopin M; Polge E; Forcade E; Ganser A; Volin L; Michallet M; Blaise D; Yakoub-Agha I; Maertens J; Espiga CR; Cornelissen J; Finke J; Mohty M; Esteve J; Nagler A
Haematologica; 2020; 105(2):414-423. PubMed ID: 31048355
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
[TBL] [Abstract][Full Text] [Related]
4. Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
Middeke JM; Beelen D; Stadler M; Göhring G; Schlegelberger B; Baurmann H; Bug G; Bellos F; Mohr B; Buchholz S; Schwerdtfeger R; Martin H; Hegenbart U; Ehninger G; Bornhäuser M; Schetelig J;
Blood; 2012 Sep; 120(12):2521-8. PubMed ID: 22855604
[TBL] [Abstract][Full Text] [Related]
5. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
Poiré X; Labopin M; Polge E; Volin L; Finke J; Ganser A; Blaise D; Yakoub-Agha I; Beelen D; Forcade E; Lioure B; Socié G; Niederwieser D; Labussière-Wallet H; Maertens J; Cornelissen J; Craddock C; Mohty M; Esteve J; Nagler A
Am J Hematol; 2020 Mar; 95(3):282-294. PubMed ID: 31876307
[TBL] [Abstract][Full Text] [Related]
6. Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
Strickland SA; Sun Z; Ketterling RP; Cherry AM; Cripe LD; Dewald G; Fernandez HF; Hicks GA; Higgins RR; Lazarus HM; Litzow MR; Luger SM; Paietta EM; Rowe JM; Vance GH; Wiernik P; Wiktor AE; Zhang Y; Tallman MS;
Leuk Res; 2017 Aug; 59():55-64. PubMed ID: 28551161
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic syndrome preceding acute myeloid leukemia with der t [7:17][q12; q11], monosomy, 17 and 5p-.
Tadmor T; Vadazs Z; Dar H; Laor R; Attias D
J Pediatr Hematol Oncol; 2006 Aug; 28(8):544-6. PubMed ID: 16912598
[TBL] [Abstract][Full Text] [Related]
8. Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization.
Mehrotra M; Luthra R; Ravandi F; Sargent RL; Barkoh BA; Abraham R; Mishra BM; Medeiros LJ; Patel KP
Leuk Lymphoma; 2014 Nov; 55(11):2538-48. PubMed ID: 24446873
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics.
Nazha A; Kantarjian HM; Bhatt VR; Nogueras-Gonzalez G; Cortes JE; Kadia T; Garcia-Manero G; Abruzzo L; Daver N; Pemmaraju N; Quintas-Cardama A; Ravandi F; Keating M; Borthakur G
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):163-71. PubMed ID: 24461514
[TBL] [Abstract][Full Text] [Related]
10. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
[TBL] [Abstract][Full Text] [Related]
11. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
12. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
13. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
Schoch C; Kohlmann A; Dugas M; Kern W; Hiddemann W; Schnittger S; Haferlach T
Leukemia; 2005 Jul; 19(7):1224-8. PubMed ID: 15902281
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Middeke JM; Fang M; Cornelissen JJ; Mohr B; Appelbaum FR; Stadler M; Sanz J; Baurmann H; Bug G; Schäfer-Eckart K; Hegenbart U; Bochtler T; Röllig C; Stölzel F; Walter RB; Ehninger G; Bornhäuser M; Löwenberg B; Schetelig J
Blood; 2014 May; 123(19):2960-7. PubMed ID: 24652988
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Effect of Complex Karyotype, Monosomal Karyotype, and Chromosome 17 Abnormalities in B-Cell Acute Lymphoblastic Leukemia.
Khoral P; Atenafu EG; Craddock KJ; Schimmer A; Chang H
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):215-219. PubMed ID: 28395813
[TBL] [Abstract][Full Text] [Related]
17. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475
[TBL] [Abstract][Full Text] [Related]
19. Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics.
Trost D; Hildebrandt B; Müller N; Germing U; Royer-Pokora B
Leuk Res; 2004 Feb; 28(2):171-7. PubMed ID: 14654082
[TBL] [Abstract][Full Text] [Related]
20. Chromosome examinations on a six-hour culture of unstimulated peripheral blood from a patient with childhood erythroleukaemia.
Selypes A; László A; Virág I
Haematologia (Budap); 1989; 22(1):19-24. PubMed ID: 2707646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
